Erick Lucera
Director of Finance/CFO at EDITAS MEDICINE, INC.
Net worth: 242 304 $ as of 2024-04-29
Profile
Erick J.
Lucera is currently serving as an Independent Director at Beyond Air, Inc., a Director at Beyond Air Ltd., an Independent Director at SAB Biotherapeutics, Inc., and the Chief Financial Officer & Executive Vice President at Editas Medicine, Inc. Previously, he held positions such as Chief Executive Officer at Triathlon Fund Management LLC, Director at Bone Biologics Corp., Vice President at Eaton Vance Management, Principal at Independence Investments LLC, Vice President-Corporate Development at Nuwellis, Inc., Portfolio Manager at Triathlon Life Sciences Fund LP, Vice President-Corporate Development at Aratana Therapeutics, Inc., Chief Financial Officer, Secretary & Treasurer at Valeritas Holdings, Inc., Principal at Pricewaterhouse & Co., Chief Financial Officer at AVEO Pharmaceuticals, Inc., and Chief Financial Officer, Secretary & Treasurer at Viventia Bio, Inc. Mr. Lucera obtained a graduate degree from Boston College, an MBA from Indiana University, and an undergraduate degree from the University of Delaware.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EDITAS MEDICINE, INC.
0.06% | 2024-04-01 | 45,441 ( 0.06% ) | 237 202 $ | 2024-04-29 |
BEYOND AIR, INC.
0.01% | 2024-03-19 | 4,342 ( 0.01% ) | 5 102 $ | 2024-04-29 |
| 2024-03-17 | 0 ( -.--% ) | - $ | 2024-04-29 |
Erick Lucera active positions
| Companies | Position | Start |
|---|---|---|
| BEYOND AIR, INC. | Director/Board Member | 2017-08-09 |
| SAB BIOTHERAPEUTICS, INC. | Director/Board Member | 2023-04-02 |
| EDITAS MEDICINE, INC. | Director of Finance/CFO | 2023-05-16 |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Director/Board Member | 2017-07-31 |
Former positions of Erick Lucera
| Companies | Position | End |
|---|---|---|
| BONE BIOLOGICS CORPORATION | Director/Board Member | 2024-01-10 |
| AVEO PHARMACEUTICALS, INC. | Director of Finance/CFO | 2023-01-31 |
| VALERITAS HOLDINGS, INC. | Director of Finance/CFO | 2019-11-30 |
Viventia Bio, Inc.
 Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Director of Finance/CFO | 2016-07-31 |
| ARATANA THERAPEUTICS INC | Corporate Officer/Principal | 2015-03-31 |
Training of Erick Lucera
| University of Delaware | Undergraduate Degree |
| Indiana University | Masters Business Admin |
| Boston College | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| NUWELLIS, INC. | Health Technology |
| BEYOND AIR, INC. | Health Technology |
| BONE BIOLOGICS CORPORATION | Health Technology |
| SAB BIOTHERAPEUTICS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| Private companies | 10 |
|---|---|
Triathlon Fund Management LLC
 Triathlon Fund Management LLC Investment ManagersFinance Triathlon Fund Management LLC is a hedge fund headquartered in Boston. | Finance |
Triathlon Life Sciences Fund LP
 Triathlon Life Sciences Fund LP Investment ManagersFinance Part of Triathlon Fund Management LLC, Triathlon Life Sciences Fund LP is a private equity fund. | Finance |
| Pricewaterhouse & Co. | Commercial Services |
Eaton Vance Management
 Eaton Vance Management Investment ManagersFinance Eaton Vance Management (EVM) is a registered mutual fund manager headquartered in Boston, Massachusetts. The firm was founded in 1979 when Eaton & Howard merged with Vance, Sanders & Co. Prior to March 2021, they were a wholly-owned subsidiary of Eaton Vance Corp. Their direct owner is Morgan Stanley Domestic Holdings, Inc., ultimately held by Morgan Stanley (NYSE: MS). EVM provides investment advice to institutional clients, mutual funds, other pooled investment vehicles, and retail separately managed accounts. | Finance |
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
Independence Investments LLC
 Independence Investments LLC Investment ManagersFinance Founded in 1982, Independence Investment LLC is a wholly owned investment management subsidiary of John Hancock Financial Services, Inc. (NYSE: JHF) The firm is located in Boston. | Finance |
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Valeritas Holdings, Inc. develops and commercializes insulin delivery devices. The company was founded by Leisa Swanson and Robert R. Gonnelli on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Health Technology |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Erick Lucera
